Print

Print


You have received this message via another mailing list. To receive these messages directly sign up
at:
http://findings.org.uk/index.php#signUp

Welcome to the Effectiveness Bank, a service provided by the Drug and Alcohol Findings project to
alert you to recent evaluation studies and reviews with important practice implications.

**************************************
LIMITS ON METHADONE TREATMENT IN NORWAY REVEAL ITS LIFESAVING POTENTIAL

Limited access to opiate substitute prescribing in Norway opened a window on its powerful lifesaving
potential, a view obscured in countries where barriers create a confounding selection effect or
where everyone who needs and wants this treatment can quickly get it. The figures suggest that if
100 people are made to wait for treatment, an extra one or two will die per year compared to a
situation where treatment was made immediately available.

To view this entry click on the link below or paste it in to your web browser's address box, being
sure to enter the whole address:
http://findings.org.uk/count/downloads/download.php?file=Clausen_T_1.txt

**************************************
Further information from [log in to unmask] or by replying to this e-mail. Drug and Alcohol
Findings is managed by DrugScope, Alcohol Concern and the National Addiction Centre, the two leading
UK drug and alcohol information charities and the UK's leading clinical/research centre. The
Effectiveness Bank project is supported by the J. Paul Getty Jr. Charitable Trust
(http://www.jpgettytrust.org.uk) and the Pilgrim Trust (http://www.thepilgrimtrust.org.uk).